Industrial Concentration Rate is Rising in China's API Market
Industrial Concentration Rate is Rising in China's API Market
Attachment: China API 0721
BEIJING--July 1, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--Under pressure amid changing medical policies and environmental regulation, the Chinese industrial market for active pharmaceutical ingredients (API) is gradually coming under the control of just a few enterprises.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects
- U.S. Home to Billions' Worth of 2Q ESG Project Kickoffs
- Japan Hosts $832 Million in CDMO/CMO-Related Pharma Projects
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
